COVID-19 Impact on Global Urinalysis Market - Future, Trends And Growth

The global urinalysis market size is projected to reach $4.9 billion by 2026. Urine tests market report provides crucial industry insights that will help your business grow.

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 moved from a regional crisis to a global pandemic in just a matter of a few weeks. The COVID-19 pandemic negatively affected the overall sales of most of the companies Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of reagents. 

According to National Kidney Foundation, people hospitalized with COVID-19 are at significant risk of (acute kidney injury) AKI, which can lead to serious illness, dialysis, and even death. The recovered COVID-19 patients who had an AKI or (acute renal failure) ARF are recommended to be seen regularly by a kidney doctor because their risk of developing chronic kidney disease is higher than others. 

Download PDF Brochure With Latest Edition @ 

COVID-19 patients who did not develop an AKI, but who had blood and/or protein in their urine, should be monitored since they are at increased risk of developing chronic- and end-stage kidney disease. With the COVID-19 pandemic, in addition to the development of vaccines and therapeutic drugs, there is a growing call for the development of more precise and simple testing technologies and the expansion of testing structures. 


The global urinalysis market size is projected to reach USD 4.9 billion by 2026 from USD 3.5 billion in 2021, at a CAGR of 7.2%. Market growth is driven by the increasing burden of UTIs, diabetes, and kidney liver diseases; rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. 

The rising geriatric population in developed and developing regions will positively influence the growth of the urinalysis market. Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes, liver, and kidney diseases are expected to increase significantly. 

The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, etc. These tests are performed by urinalysis; hence, it is expected to have a positive impact on this market. 

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:

Developing economies such as India, South Korea, Brazil, and Mexico are expected to offer potential growth opportunities for major players operating in the urinalysis market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries. 

The high investments in healthcare and life sciences research in emerging markets play an essential role in upgrading laboratory infrastructure in these countries. This, in turn, supports the installation of diagnostic systems in laboratories and leads to the growth of the urinalysis market.  

The availability of refurbished instruments acts as a challenge in the growth of this market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished systems. In particular, the markets in developing countries, which are price-sensitive, prefer instruments that are cheap and offer similar functionalities. 

Considering these factors, the demand for refurbished analyzers can be expected to increase in the coming years, as these systems offer the same functionalities at a lower cost. This is expected to hamper the revenue of companies offering branded analyzers, and thus restraining the overall growth of the market. 

The global urinalysis market is segmented into North America, Europe, Asia PacificRest of the World. In 2020, North America accounted for the largest share of the global urinalysis market. The North American urinalysis market's growth can be attributed to the growing geriatric population, implementation of favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments.


164 Vues